Nkarta (NKTX) Capital Expenditures (2019 - 2026)
Nkarta's (NKTX) quarterly Capital Expenditures came in at $413000.0 in Q1 2026, down 20.27% year-on-year from $518000.0 in Q1 2025, and down 26.25% quarter-over-quarter from $560000.0 in Q4 2025.
Nkarta (NKTX) Capital Expenditures (2019 - 2026) Analysis & Trends
Nkarta's Capital Expenditures history runs 8 years deep, the most recent figure standing at $413000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures fell 20.27% year-over-year to $413000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 76.79% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 72.6% from the prior year.
- Capital Expenditures declined to $413000.0 in Q1 2026 per NKTX's latest filing, from $560000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $35.0 million in Q4 2022 and bottomed at -$8000.0 in Q3 2025.
- The 5-year median for Capital Expenditures is $1.8 million (2022), against an average of $4.8 million.
- Across the five-year window, Capital Expenditures soared 3105.67% in 2022 and sank 101.03% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $35.0 million in 2022, then tumbled by 80.57% to $6.8 million in 2023, then plunged by 83.8% to $1.1 million in 2024, then tumbled by 49.23% to $560000.0 in 2025, then slipped by 26.25% to $413000.0 in 2026.
- Per Business Quant, the three latest NKTX Capital Expenditures figures stand at $413000.0 (Q1 2026), $560000.0 (Q4 2025), and -$8000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 413,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 413,000.00 |
| Mar 31, 2026 | 413,000.00 |
| Dec 31, 2025 | 560,000.00 |
| Dec 31, 2025 | 560,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 518,000.00 |
| Mar 31, 2025 | 518,000.00 |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 777,000.00 |
| Sep 30, 2024 | 777,000.00 |
| Jun 30, 2024 | 2.35 Mn |
| Jun 30, 2024 | 2.35 Mn |
| Mar 31, 2024 | 175,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | 6.81 Mn |
| Dec 31, 2023 | 6.81 Mn |